Skip to content

Acumen Pharmaceuticals, Inc.

ABOS· NasdaqCore metricsCIK 1576885

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -6.31%
Market cap
$15.79M
72.33M shares
Filings
365
—
—
—
-$25.37M
Q3 2026N/M FY25 yoy
-$25.81M
Q3 2026N/M FY25 yoy
-$68.86M
Q3 2026derivedN/M FY25 yoy
-$0.35
Q3 2026N/M FY25 yoy
$53.08M
Q3 2026+51.5% FY25 yoy
$15.79M
—
—
0.5×
-732.32%
—

FY2025 figures · derived

Price

$0.218388.92%$1.7517past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Total Interest and Dividend Income

$10.79MFY 2023
$10.79M0FY 2022FY 2023
PeriodEndedValueKindSource trail
FY 20232023-12-31$10,791,000reported
FY 20222022-12-31$2,392,000reported

Biological products, except diagnostic substances

Acumen Pharmaceuticals, Inc. is the 147th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Acumen Pharmaceuticals, Inc. · CIK 1576885 · Engraved from SEC EDGAR